Throughout the last three months, 4 analysts have evaluated Maravai LifeSciences (NASDAQ:MRVI), offering a diverse set of opinions from bullish to bearish. The following table provides a quick ...

Throughout the last three months, 4 analysts have evaluated Maravai LifeSciences MRVI, offering a diverse set of opinions from bullish to bearish. The following table provides a quick overview of ...

Morgan Stanley lowered the firm’s price target on Maravai Lifesciences (MRVI) to $5 from $7 and keeps an Equal Weight rating on the shares. Following a “mixed” Q4, the firm maintains an ...

NEW YORK, March 24, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI). Shareholders who purchased shares of ...

Stifel lowered the firm’s price target on Maravai Lifesciences (MRVI) to $5 from $10 and keeps a Buy rating on the shares.The firm notes Q4 revenues came up $1M light of the Street, while EBITDA ...

Greetings. Welcome to Maravai LifeSciences fourth quarter 2024 results earnings call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal ...

Greetings. Welcome to Maravai LifeSciences Fourth Quarter 2024 Results Earnings Call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal ...

Maravai Lifesciences Holdings Inc (MRVI) reported its Q4 2024 earnings, revealing a larger-than-expected loss per share and slightly lower revenue than anticipated. The company posted an adjusted EPS ...

Maravai Lifesciences Holdings Inc (MRVI) reported its Q4 2024 earnings, revealing a larger-than-expected loss per share and slightly lower revenue than anticipated. The company posted an adjusted ...

Why: Rosen Law Firm, a global investor rights law firm, reminds of purchasers of securities of Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) between August 7, 2024 and February 24 ...

LOS ANGELES, March 19, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Maravai ...